Join
Live feed
·
PRReleasevia Quantisnow
Pliant Therapeutics Inc. logo

Pliant Therapeutics Reports Positive Interim Results from Phase 2a PET Imaging Clinical Trial in Patients with Idiopathic Pulmonary Fibrosis

ByQuantisnow·Wall Street's wire, on your screen.
PLRX· Pliant Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLRX (Pliant Therapeutics Inc.) and more on Quantisnow.